Related Experiment Video
Updated: Jun 3, 2026

08:00
Dissection and Isolation of Murine Glia from Multiple Central Nervous System Regions
Published on: June 4, 2020
A new role for interferon gamma in neural stem/precursor cell dysregulation
Janine Walter1, Silke D Honsek, Sebastian Illes
1Department of Neurology, Heinrich-Heine-University, Moorenstr, 5, 40225 Düsseldorf, Germany. Janine.Walter@googlemail.com.
Molecular Neurodegeneration
|March 5, 2011
Summary
Interferon gamma (IFNγ) negatively impacts neural stem/precursor cell (NSPC) development, causing cellular dysfunction rather than enhancing neurogenesis. Inhibiting IFNγ may improve regenerative medicine strategies for neurological diseases.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Neurogenesis is crucial for regenerative medicine, with Interferon gamma (IFNγ), a pro-inflammatory cytokine, often thought to promote it.
- IFNγ is elevated in neurological diseases, making its role in neurogenesis a key area of investigation.
Purpose of the Study:
- To investigate the actual effect of IFNγ on neural stem/precursor cells (NSPCs) and their progeny.
- To determine if IFNγ enhances or compromises neurogenesis and NSPC differentiation.
Main Methods:
- In vitro culture of NSPCs exposed to IFNγ.
- Immunocytochemical analysis for cellular markers (GFAP, neuronal markers).
- Gene expression profiling and microelectrode array technology to assess functional networks.
Main Results:
- IFNγ induces a dysfunctional NSPC-derived cell population expressing both glial (GFAP) and neuronal markers.
- Abnormal gene expression and a unique functional phenotype were observed in IFNγ-exposed cells.
- IFNγ exposure during proliferation impaired subsequent neuronal differentiation and network formation.
Conclusions:
- Standard immunocytochemistry may misinterpret cellular phenotypes under inflammatory conditions; co-expression of markers indicates dysregulation.
- IFNγ negatively impacts NSPC development, contrary to previous assumptions.
- Inhibiting IFNγ's effects on NSPCs could be a therapeutic strategy for enhancing neurogenesis and regeneration in neurological disorders.
